Tert-butyl 4-((6-bromopyridin-3-yl)methyl)piperazine-1-carboxylate, 98%, 10g

1-(Benzyloxy)-4-bromo-2-ethylbenzene, 95%, 1g

(2E)-1-(3,4-dichlorophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

2-(Cyclopropylmethoxy)-5-iodopyridine, 97%, 1g

4-Bromomethylbiphenyl>98.0%(GC)25g

3-tert-Butyl-1H-pyrazol-5-amine, 98.0%, 100g

Cuillères à magnésie, 10 pièce(s)

3-cyclopropyl-4-methyl-1H-pyrazol-5-amine, 95.0%, 500mg

Mirin>95.0%(T)25mg

Ulixertinib, 250mg

(R)-3-CYCLOPROPYL-2-HYDROXYPROPANOIC ACID, 95.0%, 250mg

(4-Bromo-2-chlorophenyl)methanamine hydrochloride, 95.0%, 250mg

6-Nitrobenzo[d]thiazol-2(3H)-one, 95.0%, 250mg